Industrials·Construction & Engineering·$9.1B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.81 | N/A | -7.95% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $0.81 | N/A | -7.95% |
| Revenue | N/A | N/A | N/A |
Tone: Cautiously Optimistic
Management remains focused on executing current projects. They acknowledged the EPS miss but emphasized their commitment to future growth.
Management highlighted ongoing projects but did not provide specific revenue guidance.
They expressed confidence in the company's long-term strategy despite the EPS miss.
Argan Inc's earnings report shows a slight miss on EPS, which may raise concerns among investors. However, the stock reacted positively, increasing by 0.62%. This could indicate that investors are optimistic about the company's long-term projects despite the EPS shortfall.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
HEALTHEQUITY INC
Jun 7, 2016